SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Engel JJ. Seizures and epilepsy. Philadelphia: FA Davis, 1989.
  • 2
    Mikati MA, Holmes GL. Temporal lobe epilepsy: the treatment of epilepsies: principles and practices. Philadelphia: Lea & Febiger, 1993: 51324.
  • 3
    Kanner AM, Nieto JC. Depressive disorders in epilepsy. Neurology 1999;53(5 suppl 2):S2632.
  • 4
    Lambert MV, Robertson MM. Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia 1999;40(suppl 10):S2147.
  • 5
    Hargrave R, Martinez D, Bernstein AJ. Fluoxetine-induced seizures. Psychosomatics 1992;33: 2369.
  • 6
    Prasher VP. Seizures associated with fluoxetine therapy. Seizure 1993;2: 3157.
  • 7
    Trabert W, Hohagen F, Winkelmann G, et al. A seizure, and electroencephalographic signs of a lowered seizure threshold, associated with fluvoxamine treatment of obsessive-compulsive disorder. Pharmacopsychiatry 1995;28: 957.
  • 8
    Tobiansky RI, Lloyd GG. ECT seizure threshold and fluoxetine. Br J Psychiatry 1995;166: 263.
  • 9
    Dailey JW, Yan QS, Mishra PK, et al. Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. J Pharmacol Exp Ther 1992;260: 53340.
  • 10
    Yan QS, Jobe PC, Dailey JW. Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Eur J Pharmacol 1994;252: 10512.
  • 11
    Yan QS, Jobe PC, Cheong JH, et al. Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Arch Pharmacol 1994;350: 14952.
  • 12
    Pasini A, Tortorella A, Gale K. The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin. Brain Res 1996;724: 848.
  • 13
    Browning RA, Wood AV, Merrill MA, et al. Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors. Eur J Pharmacol 1997;336: 16.
  • 14
    Lu KT, Gean PW. Endogenous serotonin inhibits epileptiform activity in rat hippocampal CA1 neurons via 5-hydroxytryptamine1A receptor activation. Neuroscience 1998;86: 72937.
  • 15
    Saudou F, Hen R. 5-Hydroxytryptamine receptor subtypes: molecular and functional diversity. Adv Pharmacol 1994;30: 32780.
  • 16
    Pasqualetti M, Nardi I, Ladinsky H, et al. Comparative anatomical distribution of serotonin 1A, 1D alpha and 2A receptor mRNAs in human brain postmortem. Mol Brain Res 1996;39: 22333.
  • 17
    Hoyer D, Martin G. 5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharmacology 1997;36: 41928.
  • 18
    Salgado-Commissariat D, Alkadhi KA. Serotonin inhibits epileptiform discharge by activation of 5-HT1A receptors in CA1 pyramidal neurons. Neuropharmacology 1997;36: 170512.
  • 19
    Applegate CD, Tecott LH. Global increases in seizure susceptibility in mice lacking 5-HT2C receptors: a behavioral analysis. Exp Neurol 1998;154: 52230.
  • 20
    Wada Y, Hirao N, Shiraishi J, et al. Pindolol potentiates the effect of fluoxetine on hippocampal seizures in rats. Neurosci Lett 1999;267: 614.
  • 21
    Watanabe K, Ashby CR Jr, Katsumori H, et al. The effect of the acute administration of various selective 5-HT receptor antagonists on focal hippocampal seizures in freely-moving rats. Eur J Pharmacol 2000;398: 23946.
  • 22
    Mooney RD, Shi MY, Rhoades RW. Modulation of retinotectal transmission by presynaptic 5-HT1B receptors in the superior colliculus of the adult hamster. J Neurophysiol 1994;72: 313.
  • 23
    Pickard GE, Weber ET, Scott PA, et al. 5HT1B receptor agonists inhibit light-induced phase shifts of behavioral circadian rhythms and expression of the immediate-early gene c-fos in the suprachiasmatic nucleus. J Neurosci 1996;16: 820820.
  • 24
    Pickard EF, Smith BN, Belenky M, et al. 5-HT1B receptor-mediated presynaptic inhibition of retinal input to the suprachiasmatic nucleus. J Neurosci 1999;19: 403445.
  • 25
    Fuller RW. Drugs affecting serotonin neurons. Prog Drug Res 1990;35: 85108.
  • 26
    Raju SS, Noor AR, Gurthu S, et al. Effect of fluoxetine on maximal electroshock seizures in mice: acute vs. chronic administration. Pharmacol Res 1999;39: 4514.
  • 27
    Bolanos AR, Sarkisian M, Yang Y, et al. Comparison of valproate and phenobarbital treatment after status epilepticus in rats. Neurology 1998;51: 418.
  • 28
    Turski L, Ikonomidou C, Turski WA, et al. Cholinergic mechanisms and epileptogenesis: the seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 1989;3: 15471.
  • 29
    Cavalheiro EA, Leite JP, Bortolotto ZA, et al. Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia 1991;32: 77882.
  • 30
    Mello LM, Cavalhiero EA, Tan AM. Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia 1993;34: 98595.
  • 31
    Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972;32: 28194.
  • 32
    Dailey JW, Jobe PC. Anticonvulsant drugs and the genetically epilepsy-prone rat. Fed Proc 1985;44: 26404.
  • 33
    Stahl SM. The serotonin selective reuptake inhibitors: psychopharmacology of antidepressants. London: Martin Dunitz, 1997: 3960.
  • 34
    Yan QS, Jobe PC, Dailey JW. Further evidence of anticonvulsant role for 5-hydroxytryptamine in genetically epilepsy-prone rats. Br J Pharmacol 1995;115: 13148.
  • 35
    Watanabe K, Minabe Y, Ashby CR Jr, et al. Effect of acute administration of various 5-HT receptor agonists on focal hippocampal seizures in freely moving rats. Eur J Pharmacol 1998;350: 1818.
  • 36
    Gigli GL, Diomedi M, Troisi A, et al. Lack of potentiation of anticonvulsant effect by fluoxetine in drug-resistant epilepsy. Seizure 1994;3: 2214.
  • 37
    Wada Y, Shiraishi J, Nakamura M, et al. Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats. Psychopharmacology (Berl) 1995;118: 3059.
  • 38
    Levine R, Kenin M, Hoffman JS, et al. Grand mal seizures associated with the use of fluoxetine. J Clin Psychopharmacol 1994;14: 1456.
  • 39
    Lucki I, Ward HR, Frazer A. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity. J Pharmacol Exp Ther 1989;249: 15564.
  • 40
    Kitchener SJ, Dourish CT. An examination of the behavioral specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats. Psychopharmacology (Berl) 1994;113: 36977.
  • 41
    Sanchez C, Arnt J, Moltzen EK. The antiaggressive potency of (-)-penbutolol involves both 5-HT1A and 5-HT1B receptors and beta-adrenoceptors. Eur J Pharmacol 1996;297: 18.
  • 42
    De Vry J, Schreiber R. Effects of selected serotonin 5-HT(1) and 5-HT(2) receptor agonists on feeding behavior: possible mechanisms of action. Neurosci Biobehav Rev 2000;24: 34153.
  • 43
    Fish EW, Sekinda M, Ferrari PF, et al. Distress vocalizations in maternally separated mouse pups: modulation via 5-HT(1A), 5-HT(1B) and GABA(A) receptors. Psychopharmacology (Berl) 2000;149: 27785.
  • 44
    De Vry J, Eckel G, Kuhl E, et al. Effects of serotonin 5-HT(1) and 5-HT(2) receptor agonists in a conditioned taste aversion paradigm in the rat. Pharmacol Biochem Behav 2000;66: 797802.
  • 45
    O'Dell LE, Kreifeldt MJ, George FR, et al. The role of serotonin(2) receptors in mediating cocaine-induced convulsions. Pharmacol Biochem Behav 2000;65: 67781.
  • 46
    Smith BN, Sollars PJ, Dudek FE, et al. Serotonergic modulation of retinal input to the mouse suprachiasmatic nucleus mediated by 5-HT1B and 5-HT7 receptors. J Biol Rhythms 2001;16: 2538.
  • 47
    Sari Y, Miquel MC, Brisorgueil MJ, et al. Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience 1999;88: 899915.
  • 48
    Riad M, Garcia S, Watkins KC, et al. Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J Comp Neurol 2000;417: 18194.